glutathione reductase deficiency anemia Hereditary Hemolytic Anemias Due to Red Blood Cell Enzyme Disorders Glutathione system enhancement for cardiac

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)

doi: 10.3389/fnut.2022.1007816 Received 31 July 2022 Accepted 12 October 2022 Published 01 November 2022 Volume 9 - 2022 Edited by Yannan Jin, De Montfort University, United Kingdom Reviewed by Mostafa Waly, Sultan Qaboos University, Oman

Fatty acid -oxidation and the electron transfer flavoprotein system The figure shows a pathway of fatty acid -oxidation and the electron transfer flavoprotein (ETF) system

Oxidized low-density lipoprotein in inflammation-driven thrombosis

Previously, the patient was seen at his oncology clinic for evidence of cancer progression on his current chemotherapy, rituximab and polatuzumab vedotin, due to an increase in the growth of a bulky tumor on the patients back ( Figure 2 ) The patient was urgently started on a new chemotherapy regimen consisting of ifosfamide, carboplatin and etoposide